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Abstract
Background: Both haemophagocytic lymphohistiocytosis and acute necrotizing encephalopathy are life-threatening
condition. It presents major diagnostic difficulties, since it may have a diversity in clinical picture and with many
conditions leading to the same clinical presentation. So it is key important to understand the disorders.
Case presentation: We report a pediatric case of haemophagocytic lymphohistiocytosis with specific presentation
which predominantly featured as acute necrotizing encephalopathy of childhood. We discuss the diagnosis and
differential diagnosis, and speculate the etiology of haemophagocytic lymphohistiocytosis is due to hypersensitivity.
Conclusion: Haemophagocytic lymphohistiocytosis and brain damage in this case may be induced by hypersensitivity,
which have good clinical outcome if diagnosed and treated early.
Keywords: Acute necrotizing encephalopathy of childhood, Brain damage, Haemophagocytic lymphohistiocytosis,
Hypersensitivity
Background
Hemophagocytic lymphohistiocytosis (HLH) was first re-
ported by Risdall et al. [1]. It is a life-threatening condi-
tion that can rapidly deteriorate and lead to multiple
organ failure and death [2]. Cardinal symptoms of HLH
are prolonged fever, hepatosplenomegaly and cytopenias,
and characteristic laboratory findings in HLH include
hyperferritinemia, hypertriglyceridemia, cytopenia, hypo-
albuminemia, decreased fibrinogen, hypercholesterol-
emia, and abnormal liver function [3].
Acute necrotizing encephalopathy of childhood (ANEC)
represents an entity of acute encephalopathy which mani-
fests with symptoms of coma, convulsions, and hyperpy-
rexia [4]. This disease is associated with severe neurological
sequelae and profoundly high mortality [5]. ANEC is char-
acterized by multiple and symmetrical lesions with edema
and necrosis in the thalamus, the cerebral and cerebellar
medulla, and the brainstem tegmentum [4].
Haemophagocytic lymphohistiocytosis and acute nec-
rotizing encephalopathy of childhood are life-threatening
conditions with severe consequences and high mortality.
It is key important to understand the disorders. The
present paper describes the case of a 3-month-old boy
presenting with characteristic manifestation resembling
acute necrotizing encephalopathy of childhood associ-
ated with hemophagocytic lymphohistiocytosis, which
was thought due to allergic reaction.
Case presentation
The 3-month-old boy, the only child of non-
consanguineous parents, was hospitalized in Shenzhen
Children's Hospital because of persistent fever and skin
rash for more than two weeks, resistant to conventional
therapy. He had no cough, vomiting, lethargy or irritabil-
ity. His past history included allergic rashes, and his
mother suffered allergic reaction. There was no HLH
patient in his family.
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On admission, physical examination found rashes
mainly in face, trunk and limbs, liver and spleen just
palpable, no edema of palms, no periungual or perianal
desquamation, no cervical lymphadenopathy, no con-
junctival congestion, no strawberry tongue, erythema of
the oropharyngeal mucosa or cracking of the lip. No
positive neurological sign was found. Laboratory tests
showed an increase in leukocytes (20.1 × 109/L) and
neutrophils (12.82 × 109/L), erythrocyte sedimentation
rate (33 mm/h), positive antinuclear antibody and anti-
neutrophil cytoplasmic antibody, mild anemia
(hemoglobin 89 g/L) and slightly elevation of C-reactive
protein (19.5 mg/L). Liver function, lymphocyte sub-
types, immunoglobulin isotypes, serum ferritin, coagula-
tion function test and blood fat level were normal;
Serology for human immunodeficiency virus; widal test;
bacterial culture of peripheral blood, bone marrow and
urine; hepatitis A, B, and C; mycoplasma pneumoniae
(IgM and DNA); tests for tuberculosis; cytomegalovirus
(IgM, IgG, and DNA); Human Herpes Virus; Toxopasma
(IgM); Rubella (IgM); influenza virus A and B; parainflu-
enza virus; respiratory syncytial virus; adenovirus;
legionella; rickettsia; and Epstein Barr Virus (IgM, IgG
and DNA) were all negative. Echocardiography was nor-
mal. A diagnosis of acute inflammatory response syn-
drome and autoimmune vasculitis was entertained on
clinical grounds and laboratory findings. Bacterial infec-
tion could not be ruled out, then antibiotics (linezolid
and cefuroxime) and methylprednisolone was used for
3 days;the high fever subsided and the skin rash disap-
peared thereafter. 4 days later, high fever recurred and
generalized skin eruption was noted. Intravenous im-
munoglobulin (IVIG) with a dosage of 400 mg/Kg was
administered. 8 hours later, his condition deteriorated
rapidly to present with a decrease of oxygen saturation,
hypotension, tachycardia, tachypnea, irritability and
cyanosis. He was transferred to the pediatric intensive
care unit (PICU), and administration of fluids, inotropes
(dopamine, norepinephrine) and mechanical ventilation
was started. Blood routine test showed leukocyte count
10 x 109/L (neutrophil 3 %; eosinophil 40.1 %), erythro-
cyte count 3.21 x 1012/L, hemoglobin 83 g/L, platelet
count 46 x 109/L. Total IgE (104.4 KIU/L) was elevated
significantly (Table 1). Hypersensitive to IVIG was con-
sidered and high-dose intravenous methylprednisolone
(30 mg/Kg) was given. During his hospitalization in
PICU, the patient experienced several shocks each time
after transfusion of blood and blood products, including
IVIG, albumin, plasma, washed red blood cells. He
developed progressive hepatosplenomegaly, severe
pancytopenia (leukocyte count 0.2 x 109/L, erythrocyte
count 1.11 x 1012/L, hemoglobin 29 g/L, platelet count
9 x 109/L). He presented with neck stiffness, convulsion
and light coma, and his eyes couldn't follow light. Serum
ferritin (18699 ng/mL), lactate dehydrogenase (1685 IU/L)
and triglycerides (4.53 mmol/L) were elevated signifi-
cantly, but lactic acid was normal and plasma fibrinogen
was decreased apparently (0.49 g/L). Both the prothrom-
bin time and the activated partial thromboplastin time
were above limit of detection. Lumbar puncture revealed
the initial pressure of 125 mmH2O and clear cerebrospinal
fluid containing white blood cells 0 cells/L, red blood cells
28 cell/L, protein 513 mg/L. The fifth bone marrow aspir-
ation displayed large amount of hemophagocytic histio-
cytes (Fig. 1). Brain magnetic resonance imaging (MRI)
suggested ANEC (Fig. 2). DNA samples were obtained
from the peripheral blood of the patient by standard pro-
cedures, and the sequences of HLH-associated genes were
analyzed. The result verified 1 variation in the PRF1 gene,
10 variations in the UNC13D gene, 8 variations in the
STXBP2 gene, 2 variations in the XIAP gene and no varia-
tions in STX11 and SH2D1A (Table 2).
The diagnosis of hemophagocytic lymphohistiocytosis
and acute necrotizing encephalopathy was made based
on the above findings. The HLH-2004 treatment proto-
col was used once diagnosis made. The clinical symp-
toms were rapidly improved. Followed up to 3½ years
old, he was well. The neurological image (MRI) showed
slightly abnormal shape of bi-lateral ventricular, not any
other obvious abnormal noticed.
Discussion
HLH may occur either as a primary condition with a
genetic mutation or as a secondary condition associated
with an infection, immunologic disorder, malignancy, or
metabolic disease [6–8]. This patient presented with
persistent fever, skin rash, ensuing hypersensitive to all
blood products, hepatosplenomegaly, pancytopenia, and
central nervous symptoms. He fulfilled 5 of the 8 criteria
for acquired HLH [9]. Hemophagocytosis is one of the
criteria and reported to be negative at diagnosis in about
20-25 % of cases as reported before and more recently
in a case series [10, 11]. As some researcher reported
that the repetitive bone marrow aspirations may reveal
hemophagocytosis in the further course [12]. No hemo-
phagocytosis was detected in the first four bone mar-
rows in this case, but the fifth bone marrow biopsy
displayed large amount of hemophagocytic histiocytes. It
is important to note that the diagnosis of HLH does not
depend on this morphological finding. The genes rele-
vant to familial HLH (FHLH) including PRF1, UNC13D,
STX11, STXBP2 [3], were analyzed to confirm the
mutations, as well the genes related to immune defi-
ciency syndromes associated with HLH: XIAP and
SH2D1A [3, 13]. Sequencing results showed that all
these variations were synonymous or in intron region
and untranslated region. Analysis of the genetic data re-
vealed that no variation was likely to produce modified
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Table 1 The main laboratory parameters detected in this patient
Laboratory parameters Reference value Results
Rheumatoid factor 0–20 IU/ml <20
Anti-streptolysin “O” 0–200 IU/ml <25
C-reactive protein 0–10 mg/L 19.5
Anti-cyclic-citrullinated peptide antibody – Negative
Autoantibodies Antinuclear antibody – Positive
Antineutrophil cytoplasmic antiboby – Positive
Anti jo-1 antibody – Negative
Anti-centromere antibody – Negative
Anti-double-stranded dna antibody – Negative
Anti-histone antibody – Negative
Antismith antibody – Negative
Anti-rnp antibody – Negative
Anti-SS A antibody – Negative
Anti-SS B antibody – Negative
Anti-ribosomal antibody – Negative
Anti-Sc1-70 antibody Negative
Anti-nucleosome antibody – Negative
Lymphocyte subsets
(Flow cytometry)
CD3+ T cell 68 % ± 10.7 % 66.1 %
CD4+ T cell 31.5 % ± 8.8 % 34.2 %
CD8+ T cell 25.7 % ± 6.5 % 19.66 %
CD19 B cell 15.6 % ± 5.8 % 19.1 %
NK cell 5.6 % - 31 % 9 %
CD4+/CD8+ 1.5 ± 0.5 1.74
Ig isotypes IgG 3.22 – 14.0 g/L 6.39
IgM 0.57 – 1.41 g/L 0.82
IgA 0.24 – 1.79 g/L 0.43
Complement C3 0.8 – 1.6 g/L 0.74
Complement C4 0.1 – 0.4 g/L 0.18
Total IgE 0 – 20 KIU/L 104.4
Ammonia 9 – 30 umol/L 19
Lactic acid 0.7 – 2.1 mmol/L 1.22
Coagulation test Activated partial thromboplastin time 26.1 – 40.73 s 29.7a, over the upper limit of detectionb
Prothrombin time 9.3 –12.9 s 12.8a, over the upper limit of detectionb
International normalized ratio 0.72 – 1.15 1.09a, over the upper limit of detectionb
Thrombin time 13.2 – 20.1 s 20a, over the upper limit of detectionb
Fibrinogen 1.57 – 3.93 g/L 2.43a, 0.49b
Blood lipid levels Total cholesterol 3.1 – 5.8 mmol/L 1.78a, 3.62b
Triglyceride 0.23 – 1.7 mmol/L 2.54a, 4.53b
High density lipoprotein 0.9 – 1.8 g/L 0.47a, 1.05b
Low density lipoprotein 2.07 – 4.1 g/L 1.1a, 1.8b
Serum ferritin 22 – 322 ng/ml 15.4a, 18699b
Values of eosinophils 0.02 – 0.5 × 109/L 0.26a, 4.01c, 0.01d
Note: a - on admission, b - peak period of disease, c - the 2nd day after first IVIG, d - when severe pancytopenia
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amino acid sequence, thus to cause a severe impairment
of protein function in this patient, with addition of the
fact that there was no HLH patient or consanguinity in
his family. This information is therefore relevant in that
it is not likely to be genetic HLH.
This patient presented with neck stiffness, convulsion
and light coma; and the severe lesions of brain MRI
showed changes mainly in thalamus, basal ganglia,
brainstem and white matter as described in patients with
ANEC [14, 15], which is characterized by multiple and
symmetrical lesions with edema and necrosis in the
thalamus, the cerebral and cerebellar medulla, and the
brainstem tegmentum [4, 16], which evoked the diagno-
sis of acute necrotizing encephalopathy of childhood.
The clinical feature of typical ANEC is fulminant, with
severe neurologic sequelae and profoundly high mortal-
ity [17]. However, the discrepancy between the severe
MRI findings, the relatively mild neurological manifesta-
tions, and the unexpected clinical outcome was not con-
sistent with ANEC. We speculated that the brain
damage was not true ANEC, but it was caused by transi-
ent ischemia induced by allergic vasculitis due to
Fig. 1 Hemophagocytic histiocytes in bone marrow. Bone marrow
aspiration showing a normal histiocyte (a), a hemophagocytic
histiocyte containing aphagocytosed neutrophil and platelets (b), a
hemophagocytic histiocyte containing aphagocytosed erythroblast
and platelets (c). (Wright staining; ×1000)
Fig. 2 Neurological images. Brain magnetic resonance imaging (MRI) on admission revealed extensive edema (a); after 4 weeks, it showed long
T2 signal (b) and hyperintensity on fluid-attenuated inversion recovery (FLAIR, c) mainly in thalamus, basal ganglia, brainstem. 1 year later, the
neurological image (MRI) showed slightly abnormal shape of bi-lateral ventricular, not any other obvious abnormal changes noticed (d)
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hypersensitivity. The extensive allergic vasculitis involves
central nerve system, and extravasation of plasma takes
place secondary to local vascular lesions. This is
followed by destruction and necrosis of glial cells and
neurons [18]. The neurological signs were improved
promptly with the subsiding of hypersensitivity, which
gave a good interpretation to our speculation.
The central nervous system (CNS) involvement was
reported in about a third of the children with HLH,
which could easily be misdiagnosed in many children
because its radiologic manifestations are nonspecific
and overlap with various infectious and inflammatory
disorders. Therefore, differential diagnosis of resem-
bling diseases is very important for this patient. A
wide range of disorders should be considered in the
differential diagnosis, including Leigh disease, hypoxic-
ischemic encephalopathy, viral encephalitis, hemorrhagic
encephalitis, acute disseminated encephalomyelitis, and
Reye syndrome. First of all, the brain damages focused on
thalami and brainstem was not consistent with CNS in-
volvement in HLH [18]. Absence of inflammatory cells in
cerebrospinal fluid and the symmetric brain lesions in this
case differentiates from the entities of acute disseminated
encephalomyelitis and acute hemorrhagic encephalitis.
Reye syndrome can be excluded by hyperammonemia,
hypoglycemia, and lactic acidosis absent in this case [19],
as well as Leigh disease. The differentiation from hypoxic-
ischemic encephalopathy presented much more difficulty
in this patient. In spite of shocks, the oxygen saturation,
heart rate and blood pressure were corrected quickly,
which did not influence cerebral perfusion severely. More-
over, the imaging findings could not explain hypoxic-
ischemic brain damage which focuses on obscuration of
grey-white matter junctions and widespread laminar ne-
crosis of the cortex [20]. Furthermore, certain viral en-
cephalitis may be difficult to exclude clinically e.g.
Japanese encephalitis may also involve the deep gray mat-
ter symmetrically. However, the involvement of the brain
stem is uncommon in Japanese encephalitis, and thalamic
involvement is not necessarily symmetrical [21].
The etiologies of acquired HLH and ANEC were
suggested to be associated with infectious, metabolic,
immune related causes [6, 7, 15], and hypersensitivity
was more recently reported to be complicated by
hemophagocytic lymphohistiocytosis in a case series
[22–24]. This boy did not meet the diagnostic criteria
Table 2 Variations of the HLH related genes and the references [34]
Gene Exons Function Variation rs number MAF Clinical significance
PRF1 EXON3 Synonymous c.900C > T p.His300His rs885822 0.3041
UNC13D EEXON1 Intron c.117 + 59C > T rs3744010 0.2847
EXON4 Synonymous c.279C > T p.Pro93Pro rs3744007 0.1000
EXON5 Intron c.388 + 122C > T rs3744006 0.4930
EXON11 Synonymous c.888G > C p.Pro296Pro rs7223416 0.4902
EXON18 Intron c.1596 + 36A > G rs3744026 0.3083
EEXON19 Intron c.1728-48 T > C rs3744024 0.3025
EXON21 Synonymous c.1977C > T p.Thr659Thr rs2290770 0.0799
EXON24 Intron c.2299-46C > T rs7212635 0.2542
EXON28 Intron c.2709 + 48C > T rs2290768 0.2530
EEXON32 Synonymous c.3198A > G.Glu1066Glu rs7210574 0.4738
STX11 No mutation
STXBP2 Exon2 Intron c.38-7C > T rs113939878 NA acceptor
Exon10 Synonymous c.816 C > T p.Ser272Ser rs78010345 0.0034
EXON15 Intron c.1247-43 T > C rs929807 0.4730
EXON15 Intron c.1356 + 18A > G rs889187 0.4836
Exon16 Synonymous c.1443 T > C .Asp481Asp rs10001 0.4958
Exon18 Intron c.1696 + 28G > C rs34976997 0.3157
Exon18 Intron c.1696 + 77G > A rs794074 0.4615
Exon19 Intron c.1697-26 T > G rs794073 0.465
XIAP Exon5 Intron c.1099 + 264G > C rs28382732 0.2638
Exon7a 3' UTR c.*12A > G rs28382740 0.2673
SH2D1A No mutation
Note: MAF - minor allele frequency; UTR, untranslated region
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of systemic lupus erythematosus [25], and there was
no arthritis during the disease course so he was not
consistent with the diagnosis of juvenile idiopathic
arthritis [26]; moreover, there was not any evidence
of scleroderma and mixed connective tissue disease,
though he was detected anti-nuclear and anti-
neutrophil auto-antibodies and severe pancytopenia.
He suffered allergy in his past and had positive
allergy family history; eosinophils and IgE significantly
elevated after IVIG and blood transfusion then
gradually declined followed steroids; furthermore, he
was hypersensitive to all kinds of blood and blood
products, and subsequently, developed cytopenias. All
above, it led us to speculate that allergic reaction was
involved in the pathogenesis of HLH and brain lesions in
this patient. This was never reported previously.
Increase of eosinophils and reaction to blood products
suggests type I, II and III hypersensitivity was involved
in the pathogenesis in this case. Hypersensitivity and
HLH appear somewhat similar, being characterized by
activated lymphocytes and hypercytokinemia [27].
Hypersensitivity results in hypercytokinemia, leading
to uncontrolled activation of benign scavenger macro-
phages and development of hemophagocytosis [22].
The pathogenesis of HLH involves the dysfunction of
natural killer (NK) cells and cytotoxic T cells leading
to prolonged and intense activation of antigen-
processing cells (macrophages and histiocytes) [28]
and CD8+ T cells, and excessive proliferation and ec-
topic migration of T cells, which triggers overproduc-
tion of proinflammatory cytokines, and unrestrained
hemophagocytosis [29]. It is suggested that cell
destruction by cytotoxic antibodies and a reversible
depression of stem cell activity with myeloid matur-
ation blockade contribute to the pathophysiology of
the cytopenias. The deposited immune complexes can
trigger neutrophils to release free radicals and
enzymes causing tissue destruction, which can lead to
endothelial cell necrosis [30]. Hypercytokinemia and
the hyperpermeability of both the blood-brain barrier
and the capillary walls of the central nervous system
might be essential in the pathogenesis of acute necro-
tizing encephalopathy [31].
Hemophagocytic lymphohistiocytosis has a poor
prognosis [32]. Patients with secondary HLH have
had only a 55 % survival at 3 years [33]. This boy
was followed up regularly after continuation therapy.
Followed up to 3½ years old, he is doing well; there is
not any symptom that could be due to central
nervous system dysfunction; the routine blood count,
blood lipid level, liver function and ferritin were
normal, and the bone marrow cytology demonstrated
sustained remissions. The neurological image (MRI)
showed no obvious abnormal.
Conclusions
This is a rare case of hemophagocytic lymphohistiocyto-
sis, with specific presentation resembling ANEC. Hyper-
sensitivity may involve in the etiologies of HLH and
brain damage, which have good clinical and neurologic
outcome if treated early. From this study, we should
have the awareness of such a rare disease as delay of
diagnosis and treatment is common with subsequent
poor outcome. Early diagnosis is crucial to reduce
mortality rates. It is of importance to know that hyper-
sensitivity may result in HLH and brain damage resem-
bling ANEC from the findings in this study.
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